Lack of association of Guillain-Barré syndrome with vaccinations

Clinical Infectious Diseases

Volumn 57, Issue 2, 2013, Pages 197-204

  Baxter, Roger ^a   Bakshi, Nandini ^b   Fireman, Bruce ^a   Lewis, Edwin ^a   Ray, Paula ^a   Vellozzi, Claudia ^c   Klein, Nicola P ^a  

^a KAISER PERMANENTE   (United States)

^b KAISER PERMANENTE MEDICAL CENTER   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Guillaine Barr syndrome; immunizations; influenza; safety; vaccine

Indexed keywords

DIPHTHERIA VACCINE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; INFLUENZA VACCINE; PNEUMOCOCCUS POLYSACCHARIDE; PNEUMOCOCCUS VACCINE; TETANUS TOXOID; TRIVALENT INACTIVATED INFLUENZA VACCINE; UNCLASSIFIED DRUG; VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; COHORT ANALYSIS; FEMALE; GUILLAIN BARRE SYNDROME; HUMAN; INCIDENCE; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SCHOOL CHILD; SEASONAL VARIATION; VACCINATION; WINTER;

GUILLAINE-BARRÉ SYNDROME; IMMUNIZATIONS; INFLUENZA; SAFETY; VACCINE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CALIFORNIA; CHILD; CHILD, PRESCHOOL; FEMALE; GUILLAIN-BARRE SYNDROME; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; VACCINATION; YOUNG ADULT;

EID: 84879625683     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cit222     Document Type: Article

References (41)

1. Hughes RA, Cornblath DR. Guillain-Barre syndrome. Lancet 2005; 366:1653-66.
2. Sejvar JJ, Baughman AL, Wise M, Morgan OW. Population incidence of Guillain-Barre syndrome: A systematic review and meta-analysis. Neuroepidemiology 2011; 36:123-33.
3. Hardy TA, Blum S, McCombe PA, Reddel SW. Guillain-Barre syndrome: modern theories of etiology. Curr Allergy Asthma Rep 2011; 11:197-204.
4. Yuki N, Hartung HP. Guillain-Barre syndrome. N Engl J Med 2012; 366:2294-304.
5. Lehmann HC, Hartung HP, Kieseier BC, Hughes RA. Guillain-Barre syndrome after exposure to influenza virus. Lancet Infect Dis 2010; 10:643-51.
6. Jacobs BC, Rothbarth PH, van der Meche FG, et al. The spectrum of antecedent infections in Guillain-Barre syndrome: A case-control study. Neurology 1998; 51:1110-5.
7. Tam CC, O'Brien SJ, Rodrigues LC. Influenza, Campylobacter and Mycoplasma infections, and hospital admissions for Guillain-Barre syndrome, England. Emerg Infect Dis 2006; 12:1880-7.
8. Schonberger LB, Bregman DJ, Sullivan-Bolyai JZ, et al. Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976-1977. Am J Epidemiol 1979; 110:105-23.
9. Lasky T, Terracciano GJ, Magder L, et al. The Guillain-Barre syndrome and the 1992-1993 and 1993-1994 influenza vaccines. N Engl J Med 1998; 339:1797-802.
10. Langmuir AD, Bregman DJ, Kurland LT, Nathanson N, Victor M. An epidemiologic and clinical evaluation of Guillain-Barre syndrome reported in association with the administration of swine influenza vaccines. Am J Epidemiol 1984; 119:841-79.
11. Lee GM, Greene SK, Weintraub ES, et al. H1N1 and seasonal influenza vaccine safety in the vaccine safety datalink project. Am J Prev Med 2011; 41:121-8.
12. Dieleman J, Romio S, Johansen K, Weibel D, Bonhoeffer J, Sturkenboom M. Guillain-Barre syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine: multinational case-control study in Europe. BMJ 2011; 343:d3908.
13. Juurlink DN, Stukel TA, Kwong J, et al. Guillain-Barre syndrome after influenza vaccination in adults: A population-based study. Arch Intern Med 2006; 166:2217-21.
14. Tokars JI, Lewis P, Destefano F, et al. The risk of Guillain-Barre syndrome associated with influenza A (H1N1) 2009 monovalent vaccine and 2009-2010 seasonal influenza vaccines: results from self-controlled analyses. Pharmacoepidemiol Drug Saf 2012; 21:546-52.
15. Hughes R, Rees J, Smeeton N, Winer J. Vaccines and Guillain-Barre syndrome. BMJ 1996; 312:1475-6.
16. Newton N Jr, Janati A. Guillain-Barre syndrome after vaccination with purified tetanus toxoid. South Med J 1987; 80:1053-4.
17. Khamaisi M, Shoenfeld Y, Orbach H. Guillain-Barre syndrome following hepatitis B vaccination. Clin Exp Rheumatol 2004; 22:767-70.
18. Siddiqui A, Usmani RI, Anwer S, Afsar S. Guillain-Barre syndrome occurring after rabies vaccination. J Pak Med Assoc 2005; 55:87-8.
19. Stratton K, Ford A, Rusch E, Clayton EW, eds. IOM (Institute of Medicine). Adverse effects of vaccines: evidence and causality. Washington, DC: National Academies Press, 2011.
20. Stratton KR, Howe CJ, Johnston RB, Institue of Medicine (U.S.). Vaccine Safety Committee, National Institute of Allergy and Infectious Diseases (U.S.). Adverse events associated with childhood vaccines: evidence bearing on causality.Washington, D.C National Academy Press, 1994.
21. Greene SK, Rett M, Weintraub ES, et al. Risk of confirmed Guillain- Barre syndrome following receipt of monovalent inactivated influenza A (H1N1) and seasonal influenza vaccines in the Vaccine Safety Datalink Project, 2009-2010. Greene: Am J Epidemiol 2012; 175:1100-9.
22. Wise ME, Viray M, Sejvar JJ, et al. Guillain-Barre syndrome during the 2009-2010 H1N1 influenza vaccination campaign: population-based surveillance among 45 million Americans. Wise: Am J Epidemiol 2000; 175:1100-9.
23. Fiore AE, Uyeki TM, Broder K, et al. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep 2010; 59 (RR-8):1-62.
24. Gordon NP. Similarity of the adult Kaiser Permanente membership in Northern California to the insured and general population in Northern California: statistics from the 2007 California Health Interview Survey. Oakland, CA: Kaiser Permanente Division of Research, 2012.
25. Greene SK, Shi P, Dutta-Linn MM, et al. Accuracy of data on influenza vaccination status at four Vaccine Safety Datalink sites. Am J Prev Med 2009; 37:552-5.
26. Sejvar JJ, Kohl KS, Gidudu J, et al. Guillain-Barre syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine 2011; 29:599-612.
27. Ruts L, Drenthen J, Jacobs BC, van Doorn PA. Distinguishing acuteonset CIDP from fluctuating Guillain-Barre syndrome: A prospective study. Neurology 2010; 74:1680-6.
28. Baxter R, Ray GT, Fireman BH. Effect of influenza vaccination on hospitalizations in persons aged 50 years and older. Vaccine 2010; 28: 7267-72.
29. Klein NP, Fireman B, Yih WK, et al. Measles-mumps-rubella-varicella combination vaccine and the risk of febrile seizures. Pediatrics 2010; 126:e1-8.
30. Rowhani-Rahbar A, Klein NP, Lewis N, et al. Immunization and Bell's palsy in children: A case-centered analysis. Am J Epidemiol 2012; 175:878-85.
31. Schonberger LB, Hurwitz ES, Katona P, Holman RC, Bregman DJ. Guillain-Barre syndrome: its epidemiology and associations with influenza vaccination. Ann Neurol 1981; 9(suppl):31-8.
32. Fireman B, Lee J, Lewis N, Bembom O, van der Laan M, Baxter R. Influenza vaccination and mortality: differentiating vaccine effects from bias. Am J Epidemiol 2009; 170:650-6.
33. Baxter R, Lee J, Fireman B. Evidence of bias in studies of influenza vaccine effectiveness in elderly patients. J Infect Dis 2010; 201:186-9.
34. McGrogan A, Madle GC, Seaman HE, de Vries CS. The epidemiology of Guillain-Barre syndrome worldwide: A systematic literature review. Neuroepidemiology 2009; 32:150-63.
35. Chroni E, Papapetropoulos S, Gioldasis G, Ellul J, Diamadopoulos N, Papapetropoulos T. Guillain-Barre syndrome in Greece: seasonality and other clinico-epidemiological features. Eur J Neurol 2004; 11:383-8.
36. Hughes RA, Charlton J, Latinovic R, Gulliford MC. No association between immunization and Guillain-Barre syndrome in the United Kingdom, 1992 to 2000. Arch Intern Med 2006; 166:1301-4.
37. Andrews N, Stowe J, Al-Shahi Salman R, Miller E. Guillain-Barre syndrome and H1N1 (2009) pandemic influenza vaccination using an AS03 adjuvanted vaccine in the United Kingdom: self-controlled case series. Vaccine 2011; 29:7878-82.
38. Destefano F, Vellozzi C, Schonberger LB, Chen RT. Safety of adjuvanted pandemic influenza A (H1N1) 2009 vaccines. BMJ 2011; 343: d4159.
39. Update: Guillain-Barre syndrome among recipients of Menactra meningococcal conjugate vaccine - United States, October 2005-February 2006. MMWR Morb Mortal Wkly Rep 2006; 55:364-6.
40. Velentgas P. Meningococcal vaccine study: final study results. In: Meeting of the Advisory Committee on Immunization Practices, Atlanta, GA, 23 June 2010.
41. Rowhani-Rahbar A, Klein NP, Dekker CL, et al. Biologically plausible and evidence-based risk intervals in immunization safety research. Vaccine 2012; 31:271-7.